Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. CbdMD, Inc.
  6. Company
    YCBD   US12482W1018

CBDMD, INC.

(YCBD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
cbdMD Inc, formerly Level Brands, Inc., owns and operates consumer hemp-based cannabidiol (CBD) brand, cbdMD. The CompanyÔÇÖs products categories include CBD gummies, CBD tinctures, CBD topical, CBD bath bombs, CBD Vape oils and CBD pet products.

Number of employees : 165 people.
Sales per Business
20192020Delta
USD (in Million)%USD (in Million)%
Consumer (E-Commerce)14.7762.5%30.4672.7% +106.17%
Wholesale8.8837.5%11.3827.2% +28.14%
Sales per region
20192020Delta
USD (in Million)%USD (in Million)%
United States23.65100%41.88100% +77.09%
Managers
NameAgeSinceTitle
Martin A. Sumichrast532019Chairman & Co-Chief Executive Officer
Raymond Scott Coffman582020President, Co-Chief Executive Officer & Director
T. Ronan Kennedy402021Chief Operating & Financial Officer
Sibyl Swift, Dr.-2021Vice President-Scientific & Regulatory Affairs
Bakari Sellers352017Independent Director
Peter J. Ghiloni692019Independent Director
William F. Raines602019Independent Director
Scott G. Stephen542019Independent Director
Sim Farar-2021Independent Director
John Weston--Director-Investor Relations
Members of the board
NameAgeSinceTitle
Martin A. Sumichrast532019Chairman & Co-Chief Executive Officer
Bakari Sellers352017Independent Director
Raymond Scott Coffman582020President, Co-Chief Executive Officer & Director
Peter J. Ghiloni692019Independent Director
William F. Raines602019Independent Director
Scott G. Stephen542019Independent Director
Sim Farar-2021Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 56,418,287 35,945,344 63.7% 0 0.0% 63.7%
Stock B 0 2,800,000 0 0.0% 0 0.0%
Shareholders
NameEquities%
Raymond Scott Coffman 15,360,032 27.2%
William F. Raines 3,775,924 6.69%
Justice Family Office LLC 2,309,378 4.09%
AdvisorShares Investments LLC 2,284,128 4.05%
Merlin Capital LLC 1,669,134 2.96%
Martin A. Sumichrast 1,475,949 2.62%
The Vanguard Group, Inc. 1,285,129 2.28%
Global X Management Co. LLC 1,007,845 1.79%
Bridgeway Capital Management LLC 758,700 1.34%
Uniplan Investment Counsel, Inc. 741,476 1.31%
Sector Other Pharmaceuticals
1st jan.Capitalization (M$)
CBDMD, INC.15.25%194
JOHNSON & JOHNSON4.82%434 405
ROCHE HOLDING AG10.68%328 612
PFIZER, INC.9.07%224 747
NOVARTIS AG-0.39%208 035
ABBVIE INC.7.72%203 857
ELI LILLY AND COMPANY32.72%203 704
NOVO NORDISK A/S21.13%193 164
MERCK & CO., INC.-6.76%193 120
ASTRAZENECA PLC13.87%154 435
BRISTOL-MYERS SQUIBB COMPANY8.56%150 360
AMGEN INC.5.59%139 484
SANOFI12.96%134 500
GLAXOSMITHKLINE PLC4.58%99 056
JIANGSU HENGRUI MEDICINE CO., LTD.-21.45%72 637
CHUGAI PHARMACEUTICAL CO., LTD.-20.44%65 563
ALLERGAN PLC0.97%63 659
BAYER AG11.04%63 542
TAKEDA PHARMACEUTICAL COMPANY LIMITED0.64%53 877
DAIICHI SANKYO COMPANY, LIMITED-27.20%44 921
ASTELLAS PHARMA INC.20.98%32 631